# HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation

> **NCT06918665** · PHASE1 · SUSPENDED · sponsor: **Murdoch Childrens Research Institute** · enrollment: 52 (estimated)

## Conditions studied

- Scabies

## Interventions

- **DRUG:** ivermectin infant formula preparation
- **DRUG:** Standard ivermectin 3mg tablet

## Key facts

- **NCT ID:** NCT06918665
- **Lead sponsor:** Murdoch Childrens Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2026-07
- **Primary completion:** 2027-07-01
- **Final completion:** 2027-08-01
- **Target enrollment:** 52 (ESTIMATED)
- **Why stopped:** Difficulty in finalising the intervention
- **Last updated:** 2026-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06918665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06918665, "HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT06918665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*